IC
TEVA icon

Intersect Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Intersect Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,278
Closed -$516K – 107
2016
Q2 		$516K Hold
10,278
– – 0.31% 62
2016
Q1 		$550K Buy
10,278
+4,570
+80% +$268K 0.35% 58
2015
Q4 		$375K Hold
5,708
– – 0.32% 64
2015
Q3 		$322K Hold
5,708
– – 0.3% 69
2015
Q2 		$337K Hold
5,708
– – 0.29% 63
2015
Q1 		$345K Sell
5,708
-466
-8% -$27.1K 0.27% 62
2014
Q4 		$355K Buy
+6,174
New +$344K 0.3% 58

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Intersect Capital's TEVA Position: Q3 2016 in Review

Intersect Capital sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 10,278 shares — an estimated $516K sold.

Intersect Capital first reported a position in TEVA in Q4 2014 and held it in 7 quarters. The position peaked at $550K in Q1 2016. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • Intersect Capital reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Intersect Capital sold 10,278 Teva Pharmaceuticals shares in Q3 2016, an estimated $516K.
  • Intersect Capital first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 7 quarters.
  • Intersect Capital's Teva Pharmaceuticals position peaked at $550K in Q1 2016.
  • 795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Intersect Capital's 13F filing for Q3 2016, filed 27 Oct 2016.